Skip to content
Screener

Pacira BioSciences, Inc. PCRX Business Segments — Adjusted general and administrative

Similar metrics at other companies

Zoom Video Communications, Inc. logo
ZMReportable Segment — Adjusted general and administrative
$63.14M-1.2%
Anterix logo
ATEXReportable Segment — Adjusted general and administrative
$6.07M-5.2%
UiPath logo
PATHReportable Segment — Adjusted general and administrative
$39.34M+3.9%
Backblaze, Inc. logo
BLZEReportable Segment — Adjusted general and administrative
$5.1M-2.1%
Open Text logo
OTEXReportable Segment — Adjusted general and administrative
$105.48M+0.8%
New York Times logo
NYTReportable Segment — Adjusted general and administrative
$83.46M+4.0%

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$997.34M-11.9%
Enterprise value$1.26B+6.9%
P/E194.1×
P/S1.4×-0.2×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%
Net margin0.7%
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept pcrx:SellingGeneralAndAdministrativeAdjusted.

The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028871
Line itemThree Months Ended March 31, 20262025
Adjusted cost of goods sold (1)34,77032,590
Adjusted research and development (1)25,36223,101
Adjusted selling and marketing (1)58,16655,571
Adjusted general and administrative (1)25,71220,609
Stock-based compensation (1)13,53914,553
Amortization of acquired intangible assets14,32214,322
Changes in the fair value of contingent consideration(2,277)(2,675)
Legal settlement7,000

Item 1. FINANCIAL STATEMENTS (Unaudited)

FAQ

What is Pacira BioSciences, Inc.'s business segments — adjusted general and administrative?
Pacira BioSciences, Inc. (PCRX) reported business segments — adjusted general and administrative of $25.71M in Q1 2026.
How has Pacira BioSciences, Inc.'s business segments — adjusted general and administrative changed year-over-year?
Pacira BioSciences, Inc.'s business segments — adjusted general and administrative increased by 24.8% year-over-year, from $20.61M to $25.71M.
What is the long-term trend for Pacira BioSciences, Inc.'s business segments — adjusted general and administrative?
Over 3 years (2022 to 2025), Pacira BioSciences, Inc.'s business segments — adjusted general and administrative has grown at a 10.7% compound annual growth rate (CAGR), from $73.99M to $100.28M.
What does business segments — adjusted general and administrative mean?
Represents the adjusted overhead and administrative expenses required to support the operations of the reportable segment, excluding non-recurring costs. This metric helps assess the scalability and operational leverage of the segment's management structure.

Ask your AI about Pacira BioSciences, Inc.'s business segments — adjusted general and administrative.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude